1. Home
  2. RCUS vs RLJ Comparison

RCUS vs RLJ Comparison

Compare RCUS & RLJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCUS
  • RLJ
  • Stock Information
  • Founded
  • RCUS 2015
  • RLJ 2011
  • Country
  • RCUS United States
  • RLJ United States
  • Employees
  • RCUS N/A
  • RLJ N/A
  • Industry
  • RCUS Biotechnology: Pharmaceutical Preparations
  • RLJ Real Estate Investment Trusts
  • Sector
  • RCUS Health Care
  • RLJ Real Estate
  • Exchange
  • RCUS Nasdaq
  • RLJ Nasdaq
  • Market Cap
  • RCUS 1.2B
  • RLJ 1.1B
  • IPO Year
  • RCUS 2018
  • RLJ 2011
  • Fundamental
  • Price
  • RCUS $12.20
  • RLJ $7.88
  • Analyst Decision
  • RCUS Buy
  • RLJ Hold
  • Analyst Count
  • RCUS 8
  • RLJ 6
  • Target Price
  • RCUS $20.71
  • RLJ $9.55
  • AVG Volume (30 Days)
  • RCUS 772.4K
  • RLJ 2.5M
  • Earning Date
  • RCUS 11-05-2025
  • RLJ 11-05-2025
  • Dividend Yield
  • RCUS N/A
  • RLJ 7.62%
  • EPS Growth
  • RCUS N/A
  • RLJ N/A
  • EPS
  • RCUS N/A
  • RLJ 0.20
  • Revenue
  • RCUS $262,000,000.00
  • RLJ $1,367,020,000.00
  • Revenue This Year
  • RCUS N/A
  • RLJ $0.37
  • Revenue Next Year
  • RCUS N/A
  • RLJ $1.67
  • P/E Ratio
  • RCUS N/A
  • RLJ $39.51
  • Revenue Growth
  • RCUS 6.07
  • RLJ 1.40
  • 52 Week Low
  • RCUS $6.50
  • RLJ $6.16
  • 52 Week High
  • RCUS $18.98
  • RLJ $10.84
  • Technical
  • Relative Strength Index (RSI)
  • RCUS 75.43
  • RLJ 60.63
  • Support Level
  • RCUS $10.40
  • RLJ $7.54
  • Resistance Level
  • RCUS $11.84
  • RLJ $7.85
  • Average True Range (ATR)
  • RCUS 0.54
  • RLJ 0.20
  • MACD
  • RCUS 0.16
  • RLJ 0.04
  • Stochastic Oscillator
  • RCUS 98.35
  • RLJ 80.11

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

About RLJ RLJ Lodging Trust of Beneficial Interest $0.01 par value

RLJ Lodging Trust is a real estate investment trust focused on premium-branded, rooms-oriented, high-margin, focused-service, and compact full-service hotels located within the heart of demand locations. Its hotels are geographically diverse and concentrated in urban markets providing multiple demand generators from business, leisure, and other travelers. Its hotels are under the Marriott, Hilton, and Hyatt brand names. The Hotel is a single reportable segment. Its hotel segment revenues are derived from the operation of hotel properties which includes room revenue by renting hotel rooms, food and beverage revenue from the sale of food and beverages, and other revenue from parking fees, resort fees, gift shop sales, and other guest service fees.

Share on Social Networks: